Caas Capital Management LP Bio N Tech Se Put Options Transaction History

Caas Capital Management LP

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 15, 2022	BUY	$123.25 - $186.24 $431,375 - $651,840	3,500 New	3,500 $522,000
Q1 2022 May 13, 2022	SELL	$126.25 - $231.85 $2.34 Million - $4.29 Million	-18,500 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$113.32 - $241.49 $169,980 - $362,235	-1,500 Reduced 7.5%	18,500 $4.14 Million
Q1 2021 May 17, 2021	BUY	$85.73 - $119.5 $1.71 Million - $2.39 Million	20,000 New	20,000 $2.18 Million

327

40.4M

1.31M

1.37M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $19.4B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Caas Capital Management LP with notifications on news.